Sign In
Buy TRCK
$0.643
-0.0072 (-1.11%)
At Close: Jul 31, 2026
Aptevo Therapeutics Provides a 1Q26 Business Update; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection
08:05am, Wednesday, 13'th May 2026
Mipletamig continues to perform, delivers 87% clinical benefit and 81% remission in frontline AML, with no CRS in frontline patients Executive leadership transition complete. Jeff Lamothe appointed CE
i-80 Gold Reports First Quarter 2026 Results; Fully Funded Development Plan on Track
05:19pm, Tuesday, 12'th May 2026
TORONTO, May 12, 2026 /PRNewswire/ - i-80 GOLD CORP. (NYSE: IAUX) (TSX: IAU) ("i-80 Gold" or the "Company") reports its financial and operating results, as well as development highlights, for the fir
HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cel
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to zocilurtatug
Track Group Reports 2nd Quarter Fiscal 2026 Financial Results
11:00am, Friday, 08'th May 2026
NAPERVILLE, Ill., May 08, 2026 (GLOBE NEWSWIRE) -- Track Group, Inc. (OTCQB: TRCK), a global leader in offender tracking and monitoring services, today announced financial results for its fiscal quart
Quoin Pharmaceuticals Provides Corporate Update and Reports First Quarter 2026 Financial Results
08:30am, Thursday, 07'th May 2026
– Filed Breakthrough Medicine Designation Application with Saudi FDA for QRX003 in Netherton Syndrome – Submitted Application to Japanese MHLW for Orphan Drug Designation (ODD) for QRX003; MHLW Co
Armata Pharmaceuticals Secures FDA Fast Track Designation for AP-SA02
07:00am, Thursday, 07'th May 2026
Enables more frequent FDA engagement, rolling Biologic License Application review, and the potential for Accelerated Approval and Priority Review upon successful clinical development Advances AP-SA02
Neurocrine Biosciences: Core Business On Track, Soleno Deal Adds Risky Upside
06:24pm, Wednesday, 06'th May 2026
Neurocrine Biosciences delivered a strong Q1, with revenue up 42% and healthy growth in Ingrezza and Crenessity. Enhanced sales efforts could drive Ingrezza upside in 2H'26, while Crenessity has a lon
NORTHVILLE, Mich., May 6, 2026 /PRNewswire/ -- Cooper-Standard Holdings Inc. (NYSE: CPS) today reported results for the first quarter 2026.
Industry Veteran Mario J Alvarez Jr Brings $1B+ Track Record to eXp Commercial
12:00pm, Wednesday, 06'th May 2026
With over $1 billion in individual gross transaction volume and recent oversight of $5 billion in diverse national inventory, the former Marcus & Millichap Market Leader joins eXp to scale his retail
Electronic Arts Revenue Up as Net Bookings Grow; Buyout Deal Remains on Track
04:36pm, Tuesday, 05'th May 2026
The videogame maker said net bookings—a measure that combines total net revenue and the change in deferred net revenue for online-enabled games—rose to $1.86 billion from $1.8 billion.
Bunker Hill on Track for June Restart of Operations
09:47am, Monday, 04'th May 2026
Underground Exploration Drilling Intersects Multiple Zones of Near Mine High-Grade Silver Mineralization at Bunker Hill Mine Underground Exploration Drilling Intersects Multiple Zones of Near Mine Hig
Clinically significant angiokeratomas represent a rare, chronic and debilitating lymphatic malformation with no FDA-approved therapies and an estimated more than 50,000 diagnosed patients in the U.S.
Track Group Inc. Announces Completion of Comprehensive Recapitalization and Debt Refinancing
09:21am, Friday, 01'st May 2026
NAPERVILLE, Ill., May 01, 2026 (GLOBE NEWSWIRE) -- Track Group, Inc. (OTCQB: TRCK) a global leader in offender tracking and monitoring services, today announced the successful completion of a transfor
Commencement of activities in international markets is supported by the successful completion of the Limited Market Release, followed by the Recent Full Market Release in the U.S. Strong physician i
